Jukka Westerbacka
Overview
Explore the profile of Jukka Westerbacka including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
57
Citations
2458
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Sullivan S, Nicholls C, Gupta R, Menon A, Wu J, Westerbacka J, et al.
Diabetes Obes Metab
. 2019 May;
21(9):2123-2132.
PMID: 31144445
Aim: To compare glycaemic control, hypoglycaemia and treatment discontinuation of insulin glargine 300 units/mL (Gla-300) and insulin degludec (IDeg) in a real-world study of insulin-naïve adults with type 2 diabetes...
12.
Meneghini L, Mauricio D, Orsi E, Lalic N, Cali A, Westerbacka J, et al.
Diabetes Obes Metab
. 2019 Feb;
21(6):1429-1436.
PMID: 30768845
Aims: To describe in a real-world setting the achievement of physician-selected individualized HbA1c targets in individuals with type 2 diabetes, newly or recently initiated with basal insulin, and the association...
13.
Pettus J, Roussel R, Zhou F, Bosnyak Z, Westerbacka J, Berria R, et al.
Diabetes Ther
. 2019 Feb;
10(2):617-633.
PMID: 30767173
Introduction: The LIGHTNING study applied conventional and advanced analytic approaches to model, predict, and compare hypoglycemia rates of people with type 2 diabetes (T2DM) on insulin glargine 300 U/ml (Gla-300)...
14.
Sullivan S, Bailey T, Roussel R, Zhou F, Bosnyak Z, Preblick R, et al.
Diabetes Obes Metab
. 2018 Jun;
20(9):2148-2158.
PMID: 29938887
Aims: To compare clinical outcomes in patients with type 2 diabetes (T2D) switching from insulin glargine 100 units/mL (Gla-100) or insulin detemir (IDet) to insulin glargine 300 units/mL (Gla-300) or...
15.
Zhou F, Ye F, Berhanu P, Gupta V, Gupta R, Sung J, et al.
Diabetes Obes Metab
. 2017 Dec;
20(5):1293-1297.
PMID: 29272064
This retrospective cohort study compared real-world clinical and healthcare-resource utilization (HCRU) data in patients with type 2 diabetes using basal insulin (BI) who switched to insulin glargine 300 units/mL (Gla-300)...
16.
Vihonen H, Tierala I, Kuisma M, Puolakka J, Westerbacka J, Nurmi J
Scand J Trauma Resusc Emerg Med
. 2014 Jun;
22:30.
PMID: 24886984
Background: The current study was to investigate the blood glucose changes in ultra-acute phase in patients with ST-elevation myocardial infarction (STEMI) and its associations with patient outcome. Methods: This study...
17.
Expression of ceramide-metabolising enzymes in subcutaneous and intra-abdominal human adipose tissue
Kolak M, Gertow J, Westerbacka J, Summers S, Liska J, Franco-Cereceda A, et al.
Lipids Health Dis
. 2012 Sep;
11:115.
PMID: 22974251
Background: Inflammation and increased ceramide concentrations characterise adipose tissue of obese women with high liver fat content compared to equally obese women with normal liver fat content. The present study...
18.
Adiels M, Matikainen N, Westerbacka J, Soderlund S, Larsson T, Olofsson S, et al.
Atherosclerosis
. 2012 Feb;
222(1):222-8.
PMID: 22365426
Objective: To better understand the postprandial clearance of triglyceride-rich lipoproteins (TRLs) and its relation to the fasting kinetics of TRLs. Methods: Two studies were performed on 30 male subjects: a...
19.
Nurmi J, Boyd J, Anttalainen N, Westerbacka J, Kuisma M
Diabetes Care
. 2012 Jan;
35(3):510-2.
PMID: 22279029
Objective: To describe the trend of blood glucose immediately after successful resuscitation from out-of-hospital ventricular fibrillation. Research Design And Methods: Data from cardiac arrest registry supplemented with blood glucose data...
20.
Taskinen M, Adiels M, Westerbacka J, Soderlund S, Kahri J, Lundbom N, et al.
Arterioscler Thromb Vasc Biol
. 2011 Jul;
31(9):2144-50.
PMID: 21778423
Objective: Obesity increases the risk of cardiovascular disease and premature death. However, not all obese subjects develop the metabolic abnormalities associated with obesity. The aim of this study was to...